Wilex AG
Stock Exchange Xetra Stock Exchange
EPS
EUR0.46
Market Cap
EUR76.58 M
Shares Outstanding
28.16 M
Public Float
5.89 M

Profile

Address
Schriesheimer Strasse 101
Ladenburg Baden Wuerttemberg 68526
Germany
Employees -
Website http://heidelberg-pharma.com
Updated 07/08/2019
Heidelberg Pharma AG engages in the development of diagnostic and therapeutic products for the detection and targeted treatment of various types of cancer. It operates through the following segments: Customer Specific Research (Cx), Diagnostics (Dx), andTherapeutics (Rx). The Customer Specific Research segment includes preclinical and Antibody Drug Conjugate technology services.

Financials

View All
Created with Highcharts 5.0.14Wilex AGNet Income. Fiscal year is December-November. All values EUR Thousands.5 0405 0405 7015 7016 5526 5526 3896 38910 97010 97011 67211 67220132014201520162017201802.5k5k7.5k10k12.5k
Created with Highcharts 5.0.14Wilex AGSales/Revenue. Fiscal year is December-November. All values EUR Thousands.13 31713 3173 5973 5972 2842 2841 3621 3621 9001 9003 6673 66720132014201520162017201802.5k5k7.5k10k12.5k15k

Christof Hettich
Chairman-Supervisory Board
Mathias Hothum
Member-Supervisory Board